MEDDIC, explained for small sales teams

MEDDIC stands for Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain, and Champion. It was created inside PTC back in 1996 and is widely credited with helping the company grow from $300 million to $1 billion in revenue. That pedigree is real, and it's also the source of most of the confusion.

The single most important thing to understand: MEDDIC is a qualification framework, not a selling methodology. It doesn't tell you how to run a demo, handle an objection, or move a deal forward. It tells you which deals are worth your time and where a specific deal is weak. Think of it as a diagnostic, not a playbook. One veteran describes it as an X-ray for accounts, and that's the right mental model. It shows you what's broken inside a deal so you can decide whether to invest more or walk away.

MEDDIC was built for large, complex, seven-figure enterprise deals. When you force that same rigor onto a £30k annual SaaS contract that closes in two months, the framework stops being a tool and starts being overhead. A large share of reps trained on MEDDIC never sell enterprise deals at all, so they inherit a system built for a game they aren't playing.

The failure modes are predictable and worth naming, because if you recognize them you can avoid them:

Be honest before you roll anything out. If your average deal is under $100k ACV and closes in around 60 days, you probably don't need full MEDDIC at all. A lighter framework like BANT will get you most of the way there with a fraction of the overhead.

A rough rule of thumb from multiple practitioners: MEDDIC earns its keep when deals are large, involve several stakeholders, and run through a multi-week procurement process. If your deals are sub-$50K, mostly self-serve, and rarely touch legal or procurement, the heavyweight version is a tax you don't need to pay.

That said, the core principles scale down cleanly. You don't have to adopt the whole apparatus to benefit from the thinking behind it.

If you use MEDDIC as a checklist, you will slow deals down. If you use it as a lens, you will speed them up. The distinction matters. A checklist asks 'did you fill in the field?' A lens asks 'what does this deal look like when I hold it up to the light, and where's the gap?'

For smaller, faster deals, treat MEDDIC as a quick mental pass rather than a documentation exercise. On every live opportunity, run through three questions in your head or on a sticky note. What is the business pain? What metric will prove we fixed it? Who is the economic buyer? If you can answer those three cleanly, you're already ahead of most reps.

For metrics specifically, you don't need a spreadsheet or a full ROI model on a fast deal. You need a pulse check. Ask one question that reveals the magnitude of the problem, for example 'what is this costing you every month it stays broken?' That single answer tells you whether the deal is real and how urgent it is.

The framework lives or dies in deal reviews. If you run reviews as a yes-or-no checklist, you'll get compliance and no insight. The goal is to understand the buyer, not to interrogate your rep or the customer.

Instead of asking 'do we have a champion? yes or no', ask 'what did your champion do for you this week when you weren't there?' If the rep can't answer, you've found the real gap, and now you have something to coach. The same works across every pillar. Push past the field and into the evidence behind it.

This is also where the biggest risks show up. Deals commonly fall apart because the metrics were never quantified or because nobody ever reached the economic buyer. If your reviews consistently surface those two gaps early, MEDDIC is doing its job, even in a stripped-down form.